Share Statistics
| Market Cap |
$97 Billion
|
| Enterprise Value |
$101 Billion
|
| Dividend Yield |
$0.95
(0.46%)
|
| 1 Year Return |
+29.5%
|
| 52-Week High |
$210.10 |
| 52-Week Low |
$141.02 |
| Beta |
0.77 |
| Outstanding Shares |
474 Million
|
| Avg 30 Day Volume |
1.38 Million
|
Valuation
| P/E Ratio |
50.82 |
| PEG |
158.07 |
| Earnings per Share |
$3.99 |
| Price to Sales Ratio |
14.62 |
| Price to Book Ratio |
22.75 |
| Revenue to Enterprise Value |
14.34
|
| EBIT to Enterprise Value |
40.27
|
| Total Debt to Enterprise Value |
0.07
|
| Debt to Equity |
1.65
|
Profitability
| Revenue |
$7.01 Billion
|
| Gross Profit |
$4.87 Billion
|
| EBIT |
$2.5 Billion
|
| Net Income |
$1.77 Billion
|
| Profit Margin |
25.3%
|
| Quarterly Earnings Growth (YoY) |
+32.2%
|
| Return on Equity |
40.78%
|
| Return on Assets |
12.61%
|
| Return on Invested Capital |
20.85%
|
Zoetis Inc - Class A
Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 65 years of experience in animal health, Zoetis discovers, develops, manufactures and commercializes medicines, vaccines and diagnostic products, which are complemented by biodevices, genetic tests and precision livestock farming. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2019, the company generated annual revenue of $6.3 billion with approximately 10,600 employees.
News
Veterinary Vaccines Market to Reach USD 16.13 Billion with 6% CAGR by 2028; Novel Development of Easy-to-feed Medications for Dogs to Spur Growth: Fortune Business Insights
Top Players Covered in the Veterinary Vaccines Market Research Report are Elanco (Greenfield, U.S.), HIPRA (Girona, Spain), Boehringer Ingelheim International GmbH (Ingelheim am Rhein, Germany), Vi...
Intrado Digital Media,
3 days
ago
Vaccine for ASF could be developed within three years
Tim Bettington is Executive Vice President and President, U.S. Operations and Global Customer Experience with Zoetis. It could take up to three more years to develop an active solution, Bettington ...
Brownfield Ag News,
4 days
ago
BRD Treatment Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027 | Bayer HealthCare, Boehringer Ingelheim, Elanco, Merck, Zoetis, Bimeda
The BRD Treatment Market provides analysis and insights relating to the many factors expected to be rife throughout the forecast amount whereas providing their impacts on the Markets growth. The in...
OpenPR,
4 days
ago
